A rare variant in DPYD c.812delT causes severe adverse events of S-1 in a patient with tongue cancer
Cancer Chemotherapy and Pharmacology · 03.08.2026 · 96 (1)
DOI: 10.1007/s00280-026-04930-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 03.08.2026. Verfasst von Hiroki Ishimura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan. Hauptthemen laut MEDLINE: Tegafur, Dihydrouracil Dehydrogenase (NADP), Oxonic Acid, Tongue Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation, INGEM grant.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan.
- Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan. suehiro@kuhp.kyoto-u.ac.jp.
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan. hira_d@kuhp.kyoto-u.ac.jp.
- Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan. hira_d@kuhp.kyoto-u.ac.jp.
- Advanced Research Center for Innovations in Next- Generation Medicine (INGEM), Tohoku University, Sendai, Miyagi, Japan.
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.
Förderung
- Japan Society for the Promotion of Science
- Takeda Science Foundation
- INGEM grant
Zitieren
APA
Ishimura, H., Suehiro, A., Hira, D., Hishinuma, E., Kato, M., Maekawa, M., Yasuda, T., Katsube, Y., Katada, Y., Imayoshi, N., Shigetsura, Y., Nakagawa, S., Tsuda, M., Hiratsuka, M., & Terada, T. (2026). A rare variant in DPYD c.812delT causes severe adverse events of S-1 in a patient with tongue cancer. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04930-9
Vancouver
Ishimura H, Suehiro A, Hira D, Hishinuma E, Kato M, Maekawa M, et al. A rare variant in DPYD c.812delT causes severe adverse events of S-1 in a patient with tongue cancer. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04930-9
BibTeX
@article{Ishimura2026,
author = {Ishimura, Hiroki and Suehiro, Atsushi and Hira, Daiki and Hishinuma, Eiji and Kato, Midori and Maekawa, Masamitsu and Yasuda, Taishi and Katsube, Yurie and Katada, Yoshiki and Imayoshi, Natsuki and Shigetsura, Yuki and Nakagawa, Shunsaku and Tsuda, Masahiro and Hiratsuka, Masahiro and Terada, Tomohiro},
title = {A rare variant in DPYD c.812delT causes severe adverse events of S-1 in a patient with tongue cancer},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2026},
volume = {96},
number = {1},
doi = {10.1007/s00280-026-04930-9}
}
EUVIMED